Investors Similar to Ilex Medical
Discover 20 alternative investors with similar investment focus, company structure, and track record.
Target Investor
Ilex Medical
Ilex Medical was founded in 1977, and became public at 1995 (traded at TLSA). Ilex Medical is the major IVD business in Israel today representing leading worldwide companies such as bioMerieux, Abbott, Sebia, Instrumentation Laboratories , Fertilitech Life global and more, with more than 54% of the market. At 2011 ILEX has acquired 54% of Medtechnica (publically listed – trades at TLSA), which is Israel’s leading distributor and service provider of medical equipment. Both of the companies are hiring more than 220 employees. Along the years we at Ilex medical have acquired a broad experience in various medical fields, and successfully established an impressive network with leading key personnel and leading decision makers in the industry (Laboratory managers, Hospital managers, Academic professors, Government officials etc.). Today, Ilex is relying on a series of highly educated qualified personnel, consult with high rank governmental officials and use this network to enter new cutting edge products to the Israeli market. In the Israeli IVD and medical instruments industry Ilex is well known for its excellent products reliability and customer service.
Similar Investors
Showing 20 results
About This Comparison
This alternatives page shows investors with similar characteristics to Ilex Medical, including similar company structure, comparable investment focus, and track record. Use this page to discover alternative investors for your funding strategy, investor mapping, or competitive analysis.
Investors are ranked by total score, which reflects portfolio size, investment activity, and market presence on StartupHub.ai. Learn more about each investor by clicking their profile to see portfolio companies, investment rounds, and detailed information.
StartupHub.ai provides free access to investor profiles, funding data, and startup intelligence. No paywall, no enterprise subscription required.